JKJan Klatt

Jan Klatt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jan Klatt has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Henning Hanken

    Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    2 shared publications
  • Lan Kluwe

    Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    2 shared publications
  • Martin Gosau

    Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    2 shared publications
  • Ralf Smeets

    Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    2 shared publications
  • Tony Sorowka

    Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    2 shared publications
  • Anders Henningsen

    Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    1 shared publication

Latest Publications

  • Open Access

    Does a preoperative cone beam CT reduce complication rates in the surgical removal of complex lower third molars? A retrospective study including 486 cases

    by Jan C. Klatt, Tony Sorowka, Lan Kluwe, Ralf Smeets, Martin Gosau, Henning Hanken

    Backround: This study was designed to analyse the value of preoperative Cone Beam CTs (CBCT) prior to the surgical removal of complex lower third molars. Furthermore, the aim was to assess injuries to the inferior alveolar nerve (IAN) bundle and postoperative neurological disorders depending on the position of the lower third molar and the inferior alveolar nerve bundle. Methods: In this retrospective examination preoperative Cone Beam CTs and Orthopantomographs (OPT) of 324 patients were analysed concerning the location of the lower third molars in relation to the mandible and the inferior alveolar nerve bundle. Surgery protocols of all patients who underwent the surgical removal of at least one complex lower third molar were analysed concerning patient data, length of surgery, intraoperative haemorrhage, intraoperative exposure of the inferior alveolar nerve bundle, postoperative swelling and postoperative neurological disorders. The data was then compared to data from international studies. Results: In all 324 patients a permanent neurological damage was not found. Temporary neurological damage was recorded in 13 cases (2.6%). A caudal nerve position with no measurable distance to the root of the lower third molar was associated with the highest risk of a temporal neurological damage. A vestibular touching nerve route also correlated with postoperative sensitivity impairment. If a mesioangulation (Winter) or a Pell and Gregory Type IIIC appears in the OPT, risk of neurological damage is at its highest. Conclusions: Three-dimensional radiographic imaging, in our patient group, does not significantly affect the risk for complications during the surgical removal of complex lower third molars. Therefore, it should only be utilized for risk assessment, especially in cases of symptom-free lower third molars. A preoperative orthopantomogram still can be accepted as standard for radiographic imaging. An intraoperative exposure of the IAN bundle does not necessarily predict simultaneous neurological damage. Exposure of the IAN bundle is no indication for a discontinuation of the surgery.


  • Open Access

    Does a preoperative Cone Beam CT reduce complication rates in the surgical removal of complex lower third molars? A retrospective study including 486 cases.

    by Jan Klatt, Tony Sorowka, Lan Kluwe, Ralf Smeets, Martin Gosau, Henning Hanken

    Backround This study was designed to analyse the value of preoperative Cone Beam CTs (CBCT) prior to the surgical removal of complex lower third molars. Furthermore, the aim was to assess injuries to the inferior alveolar nerve (IAN) bundle and postoperative neurological disorders depending on the position of the lower third molar and the inferior alveolar nerve bundle.Methods In this retrospective examination preoperative Cone Beam CTs and Orthopantomographs (OPT) of 324 patients were analysed concerning the location of the lower third molars in relation to the mandible and the inferior alveolar nerve bundle. Surgery protocols of all patients who underwent the surgical removal of at least one complex lower third molar were analysed concerning patient data, length of surgery, intraoperative haemorrhage, intraoperative exposure of the inferior alveolar nerve bundle, postoperative swelling and postoperative neurological disorders. The data was then compared to data from international studies. Results In all 324 patients a permanent neurological damage was not found. Temporary neurological damage was recorded in 13 cases (2.6%). A caudal nerve position with no measurable distance to the root of the lower third molar was associated with the highest risk of a temporal neurological damage. A vestibular touching nerve route also correlated with postoperative sensitivity impairment. If a mesioangulation (Winter) or a Pell and Gregory Type IIIC appears in the OPT, risk of neurological damage is at its highest.Conclusions Three-dimensional radiographic imaging, in our patient group, does not significantly affect the risk for complications during the surgical removal of complex lower third molars. Therefore, it should only be utilized for risk assessment, especially in cases of symptom-free lower third molars.A preoperative orthopantomogram still can be accepted as standard for radiographic imaging. An intraoperative exposure of the IAN bundle does not necessarily predict simultaneous neurological damage. Exposure of the IAN bundle is no indication for a discontinuation of the surgery.

  • Open Access

    Assessing the frequency of deep lingual concavities in 826 posterior mandible sockets

    by Linda Bodart, Henning Hanken, Ralf Smeets, Martin Gosau, Chenxi Li, Lan Kluwe, Jan Klatt


  • Biomechanical comparison of a multidirectional locking plate and conventional plates for the osteosynthesis of mandibular angle fractures—A preliminary study

    by Catarina Zimmermann, Anders Henningsen, Kai-Olaf Henkel, Jan Klatt, Christian Jürgens, Klaus Seide, Benjamin Kienast


  • FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis

    by J. Klatt, H.-P. Hartung, R. Hohlfeld

    Sämtliche zurzeit für die Behandlung der Multiplen Sklerose zugelassenen Substanzen stehen nur in parenteraler Applikationsform zur Verfügung. Verschiedene orale Substanzen befinden sich in der klinischen Entwicklung. Eine dieser Substanzen, FTY720 (auch bekannt als Fingolimod), wird in dieser Übersicht näher beleuchtet. Es werden zunächst die biologischen Effekte von FTY720 dargestellt, im Anschluss folgen tierexperimentelle und klinische Daten. FTY720 als ein Sphingosin-1-Phosphat-Rezeptor-Agonist basiert auf einem innovativen Ansatz und greift an verschiedenen Stellen in die pathogenetische Kaskade der Multiplen Sklerose ein. In einer bislang vorliegenden Phase-II-Studie zeigt FTY720 eine viel versprechende Wirksamkeit mit einer Schubreduktion von über 50% im Vergleich zu Plazebo bei akzeptabler Verträglichkeit. Diese Ergebnisse sollen in zwei laufenden internationalen Phase-III-Studien bestätigt werden. All currently available therapeutic options for multiple sclerosis have to be administered parenterally. Several oral substances are currently in the late clinical development stage. One of them, FTY720 (also known as fingolimod) is highlighted in this review. The biological effects of FTY720 are presented as well as animal data and first clinical data from a phase II trial in multiple sclerosis patients. The effects of FTY720 are based on an innovative approach and apparently target several key elements in the pathogenesis of multiple sclerosis. The first clinical data with FTY720 show very promising results, with a relapse reduction of over 50% compared to placebo and an acceptable safety profile. These results currently await confirmation in two international phase III studies which are recruiting patients worldwide.